Global Outsourcing in Drug Discovery Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets.

    Outsourcing in Drug Discovery market report explains the definition, types, applications, major countries, and major players of the Outsourcing in Drug Discovery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pharmaceutical Product Development, LLC

    • EVOTEC

    • GenScript

    • Thermo Fisher Scientific Inc

    • WuXi AppTec

    • Charles River

    • Dalton Pharma Services

    • Merck & Co, Inc

    • Oncodesign

    • Laboratory Corporation of America Holdings

    • QIAGEN

    • Jubilant Biosys

    • DiscoverX Corporation

    • Albany Molecular Research Inc

    By Type:

    • Small Molecules

    • Large Molecules

    By End-User:

    • Hospitals and Clinics

    • Medical Laboratories

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Outsourcing in Drug Discovery Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Outsourcing in Drug Discovery Outlook to 2028- Original Forecasts

    • 2.2 Outsourcing in Drug Discovery Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Outsourcing in Drug Discovery Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Outsourcing in Drug Discovery Market- Recent Developments

    • 6.1 Outsourcing in Drug Discovery Market News and Developments

    • 6.2 Outsourcing in Drug Discovery Market Deals Landscape

    7 Outsourcing in Drug Discovery Raw Materials and Cost Structure Analysis

    • 7.1 Outsourcing in Drug Discovery Key Raw Materials

    • 7.2 Outsourcing in Drug Discovery Price Trend of Key Raw Materials

    • 7.3 Outsourcing in Drug Discovery Key Suppliers of Raw Materials

    • 7.4 Outsourcing in Drug Discovery Market Concentration Rate of Raw Materials

    • 7.5 Outsourcing in Drug Discovery Cost Structure Analysis

      • 7.5.1 Outsourcing in Drug Discovery Raw Materials Analysis

      • 7.5.2 Outsourcing in Drug Discovery Labor Cost Analysis

      • 7.5.3 Outsourcing in Drug Discovery Manufacturing Expenses Analysis

    8 Global Outsourcing in Drug Discovery Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Outsourcing in Drug Discovery Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Outsourcing in Drug Discovery Export by Region (Top 10 Countries) (2017-2028)

    9 Global Outsourcing in Drug Discovery Market Outlook by Types and Applications to 2022

    • 9.1 Global Outsourcing in Drug Discovery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Small Molecules Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Large Molecules Consumption and Growth Rate (2017-2022)

    • 9.2 Global Outsourcing in Drug Discovery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Outsourcing in Drug Discovery Market Analysis and Outlook till 2022

    • 10.1 Global Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.2.2 Canada Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.2.3 Mexico Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.2 UK Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.3 Spain Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.4 Belgium Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.5 France Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.6 Italy Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.7 Denmark Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.8 Finland Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.9 Norway Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.10 Sweden Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.11 Poland Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.12 Russia Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.3.13 Turkey Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.2 Japan Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.3 India Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.4 South Korea Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.5 Pakistan Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.6 Bangladesh Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.7 Indonesia Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.8 Thailand Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.9 Singapore Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.10 Malaysia Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.11 Philippines Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.4.12 Vietnam Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.2 Colombia Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.3 Chile Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.4 Argentina Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.5 Venezuela Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.6 Peru Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.7 Puerto Rico Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.5.8 Ecuador Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.6.2 Kuwait Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.6.3 Oman Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.6.4 Qatar Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.7.2 South Africa Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.7.3 Egypt Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.7.4 Algeria Outsourcing in Drug Discovery Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Outsourcing in Drug Discovery Consumption (2017-2022)

      • 10.8.2 New Zealand Outsourcing in Drug Discovery Consumption (2017-2022)

    11 Global Outsourcing in Drug Discovery Competitive Analysis

    • 11.1 Pharmaceutical Product Development, LLC

      • 11.1.1 Pharmaceutical Product Development, LLC Company Details

      • 11.1.2 Pharmaceutical Product Development, LLC Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pharmaceutical Product Development, LLC Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.1.4 Pharmaceutical Product Development, LLC Outsourcing in Drug Discovery Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 EVOTEC

      • 11.2.1 EVOTEC Company Details

      • 11.2.2 EVOTEC Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 EVOTEC Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.2.4 EVOTEC Outsourcing in Drug Discovery Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GenScript

      • 11.3.1 GenScript Company Details

      • 11.3.2 GenScript Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GenScript Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.3.4 GenScript Outsourcing in Drug Discovery Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Thermo Fisher Scientific Inc

      • 11.4.1 Thermo Fisher Scientific Inc Company Details

      • 11.4.2 Thermo Fisher Scientific Inc Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Thermo Fisher Scientific Inc Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.4.4 Thermo Fisher Scientific Inc Outsourcing in Drug Discovery Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 WuXi AppTec

      • 11.5.1 WuXi AppTec Company Details

      • 11.5.2 WuXi AppTec Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 WuXi AppTec Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.5.4 WuXi AppTec Outsourcing in Drug Discovery Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Charles River

      • 11.6.1 Charles River Company Details

      • 11.6.2 Charles River Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Charles River Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.6.4 Charles River Outsourcing in Drug Discovery Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Dalton Pharma Services

      • 11.7.1 Dalton Pharma Services Company Details

      • 11.7.2 Dalton Pharma Services Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Dalton Pharma Services Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.7.4 Dalton Pharma Services Outsourcing in Drug Discovery Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Merck & Co, Inc

      • 11.8.1 Merck & Co, Inc Company Details

      • 11.8.2 Merck & Co, Inc Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Merck & Co, Inc Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.8.4 Merck & Co, Inc Outsourcing in Drug Discovery Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Oncodesign

      • 11.9.1 Oncodesign Company Details

      • 11.9.2 Oncodesign Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Oncodesign Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.9.4 Oncodesign Outsourcing in Drug Discovery Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Laboratory Corporation of America Holdings

      • 11.10.1 Laboratory Corporation of America Holdings Company Details

      • 11.10.2 Laboratory Corporation of America Holdings Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Laboratory Corporation of America Holdings Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.10.4 Laboratory Corporation of America Holdings Outsourcing in Drug Discovery Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 QIAGEN

      • 11.11.1 QIAGEN Company Details

      • 11.11.2 QIAGEN Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 QIAGEN Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.11.4 QIAGEN Outsourcing in Drug Discovery Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Jubilant Biosys

      • 11.12.1 Jubilant Biosys Company Details

      • 11.12.2 Jubilant Biosys Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Jubilant Biosys Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.12.4 Jubilant Biosys Outsourcing in Drug Discovery Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 DiscoverX Corporation

      • 11.13.1 DiscoverX Corporation Company Details

      • 11.13.2 DiscoverX Corporation Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 DiscoverX Corporation Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.13.4 DiscoverX Corporation Outsourcing in Drug Discovery Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Albany Molecular Research Inc

      • 11.14.1 Albany Molecular Research Inc Company Details

      • 11.14.2 Albany Molecular Research Inc Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Albany Molecular Research Inc Outsourcing in Drug Discovery Main Business and Markets Served

      • 11.14.4 Albany Molecular Research Inc Outsourcing in Drug Discovery Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Outsourcing in Drug Discovery Market Outlook by Types and Applications to 2028

    • 12.1 Global Outsourcing in Drug Discovery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Large Molecules Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Outsourcing in Drug Discovery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Medical Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Outsourcing in Drug Discovery Market Analysis and Outlook to 2028

    • 13.1 Global Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.2.2 Canada Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.2 UK Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.3 Spain Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.5 France Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.6 Italy Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.8 Finland Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.9 Norway Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.11 Poland Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.12 Russia Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.2 Japan Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.3 India Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.3 Chile Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.6 Peru Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.3 Oman Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Outsourcing in Drug Discovery Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Outsourcing in Drug Discovery

    • Figure of Outsourcing in Drug Discovery Picture

    • Table Global Outsourcing in Drug Discovery Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Outsourcing in Drug Discovery Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Small Molecules Consumption and Growth Rate (2017-2022)

    • Figure Global Large Molecules Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Table North America Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure United States Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Canada Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Mexico Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Europe Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure Germany Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure UK Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Spain Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Belgium Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure France Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Italy Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Denmark Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Finland Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Norway Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Sweden Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Poland Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Russia Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Turkey Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table APAC Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure China Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Japan Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure India Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Thailand Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Singapore Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Philippines Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table South America Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure Brazil Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Colombia Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Chile Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Argentina Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Peru Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table GCC Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure Bahrain Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Oman Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Qatar Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Africa Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure Nigeria Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure South Africa Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Egypt Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure Algeria Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Oceania Outsourcing in Drug Discovery Consumption by Country (2017-2022)

    • Figure Australia Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Outsourcing in Drug Discovery Consumption and Growth Rate (2017-2022)

    • Table Pharmaceutical Product Development, LLC Company Details

    • Table Pharmaceutical Product Development, LLC Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmaceutical Product Development, LLC Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Pharmaceutical Product Development, LLC Outsourcing in Drug Discovery Product Portfolio

    • Table EVOTEC Company Details

    • Table EVOTEC Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table EVOTEC Outsourcing in Drug Discovery Main Business and Markets Served

    • Table EVOTEC Outsourcing in Drug Discovery Product Portfolio

    • Table GenScript Company Details

    • Table GenScript Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table GenScript Outsourcing in Drug Discovery Main Business and Markets Served

    • Table GenScript Outsourcing in Drug Discovery Product Portfolio

    • Table Thermo Fisher Scientific Inc Company Details

    • Table Thermo Fisher Scientific Inc Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Inc Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Thermo Fisher Scientific Inc Outsourcing in Drug Discovery Product Portfolio

    • Table WuXi AppTec Company Details

    • Table WuXi AppTec Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table WuXi AppTec Outsourcing in Drug Discovery Main Business and Markets Served

    • Table WuXi AppTec Outsourcing in Drug Discovery Product Portfolio

    • Table Charles River Company Details

    • Table Charles River Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Charles River Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Charles River Outsourcing in Drug Discovery Product Portfolio

    • Table Dalton Pharma Services Company Details

    • Table Dalton Pharma Services Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dalton Pharma Services Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Dalton Pharma Services Outsourcing in Drug Discovery Product Portfolio

    • Table Merck & Co, Inc Company Details

    • Table Merck & Co, Inc Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Merck & Co, Inc Outsourcing in Drug Discovery Product Portfolio

    • Table Oncodesign Company Details

    • Table Oncodesign Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oncodesign Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Oncodesign Outsourcing in Drug Discovery Product Portfolio

    • Table Laboratory Corporation of America Holdings Company Details

    • Table Laboratory Corporation of America Holdings Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Laboratory Corporation of America Holdings Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Laboratory Corporation of America Holdings Outsourcing in Drug Discovery Product Portfolio

    • Table QIAGEN Company Details

    • Table QIAGEN Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Outsourcing in Drug Discovery Main Business and Markets Served

    • Table QIAGEN Outsourcing in Drug Discovery Product Portfolio

    • Table Jubilant Biosys Company Details

    • Table Jubilant Biosys Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Biosys Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Jubilant Biosys Outsourcing in Drug Discovery Product Portfolio

    • Table DiscoverX Corporation Company Details

    • Table DiscoverX Corporation Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table DiscoverX Corporation Outsourcing in Drug Discovery Main Business and Markets Served

    • Table DiscoverX Corporation Outsourcing in Drug Discovery Product Portfolio

    • Table Albany Molecular Research Inc Company Details

    • Table Albany Molecular Research Inc Outsourcing in Drug Discovery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Albany Molecular Research Inc Outsourcing in Drug Discovery Main Business and Markets Served

    • Table Albany Molecular Research Inc Outsourcing in Drug Discovery Product Portfolio

    • Figure Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Large Molecules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Table North America Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure United States Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Germany Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure China Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Brazil Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Outsourcing in Drug Discovery Consumption Forecast by Country (2022-2028)

    • Figure Australia Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Outsourcing in Drug Discovery Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.